George Eric Davis, a director at BioMarin Pharmaceutical Inc. (BMRN), offloaded 26,061 shares of the company's stock on February 26, 2026. The transaction, executed at an average price of $61.36 per share, amounted to approximately $1.6 million.
This sale follows another significant insider transaction on the same day, with Gregory R. Friberg, another director, selling 6,326 shares for roughly $381,963.
Insider selling can occur for a variety of reasons, including portfolio diversification or tax planning. Investors often monitor such activities to gauge sentiment from company executives and directors.